Cargando…

Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up

PURPOSE: To estimate the effectiveness of complete corneal ring (MyoRing) implantation compared with MyoRing implantation combined with corneal collagen crosslinking (CXL) for keratoconus treatment for 36 months follow-up. DESIGN: Retrospective cohort study. MATERIALS AND METHODS: MyoRing implantati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikbova, Guzel, Kazakbaeva, Gyulli, Bikbov, Mukharram, Usubov, Emin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988788/
https://www.ncbi.nlm.nih.gov/pubmed/28620706
http://dx.doi.org/10.1007/s10792-017-0593-4
_version_ 1783329348808343552
author Bikbova, Guzel
Kazakbaeva, Gyulli
Bikbov, Mukharram
Usubov, Emin
author_facet Bikbova, Guzel
Kazakbaeva, Gyulli
Bikbov, Mukharram
Usubov, Emin
author_sort Bikbova, Guzel
collection PubMed
description PURPOSE: To estimate the effectiveness of complete corneal ring (MyoRing) implantation compared with MyoRing implantation combined with corneal collagen crosslinking (CXL) for keratoconus treatment for 36 months follow-up. DESIGN: Retrospective cohort study. MATERIALS AND METHODS: MyoRing implantation was performed in a series of 78 patients (80 eyes) with keratoconus II–III Amsler classification, of these 39 eyes had MyoRing implantation combined with CXL. Implantation of a MyoRing in the corneal pocket was performed using a PocketMaker microkeratome and corneal intrastromal implantation system. During CXL, riboflavin solution 0.1% was injected into the corneal pocket through the incision tunnel and standard surface UVA irradiation (370 nm, 3 mW/cm(2)) was then applied from 5-cm distance for 30 min. RESULTS: Significant improvements in uncorrected distance visual acuity and corrected distance visual acuity were observed for both groups, which was relatively better 12 months after procedure in MyoRing alone group; however, in 36 months there was no difference between groups. Keratometry was reduced in both groups; after MyoRing implantation for 8.45 D and MyoRing + CXL for 9.43 D, the spherical equivalent decreased from 8.45 to 7.72 D and from 9.43 to 6.25 D, respectively. The cylinder decreased to 3.33 D with MyoRing alone and to 3.31 D with MyoRing + CXL. Corneal thickness remained nearly unchanged (from 433.69 ± 38.76 to 434.21 ± 34.98) in MyoRing group and decreased from baseline (from 426.93 ± 46.58 to 401.24 ± 39.12 µm) in MyoRing + CXL group 36 months postoperatively, which corresponds with pachymetry reduction after conventional CXL. CONCLUSION: Both MyoRing implantation and MyoRing combined with CXL were effective for treating keratoconus. At 36 months, there were slightly better outcomes in MyoRing + CXL group; however, in MyoRing alone group visual and refractive outcomes were stable overtime.
format Online
Article
Text
id pubmed-5988788
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-59887882018-06-12 Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up Bikbova, Guzel Kazakbaeva, Gyulli Bikbov, Mukharram Usubov, Emin Int Ophthalmol Original Paper PURPOSE: To estimate the effectiveness of complete corneal ring (MyoRing) implantation compared with MyoRing implantation combined with corneal collagen crosslinking (CXL) for keratoconus treatment for 36 months follow-up. DESIGN: Retrospective cohort study. MATERIALS AND METHODS: MyoRing implantation was performed in a series of 78 patients (80 eyes) with keratoconus II–III Amsler classification, of these 39 eyes had MyoRing implantation combined with CXL. Implantation of a MyoRing in the corneal pocket was performed using a PocketMaker microkeratome and corneal intrastromal implantation system. During CXL, riboflavin solution 0.1% was injected into the corneal pocket through the incision tunnel and standard surface UVA irradiation (370 nm, 3 mW/cm(2)) was then applied from 5-cm distance for 30 min. RESULTS: Significant improvements in uncorrected distance visual acuity and corrected distance visual acuity were observed for both groups, which was relatively better 12 months after procedure in MyoRing alone group; however, in 36 months there was no difference between groups. Keratometry was reduced in both groups; after MyoRing implantation for 8.45 D and MyoRing + CXL for 9.43 D, the spherical equivalent decreased from 8.45 to 7.72 D and from 9.43 to 6.25 D, respectively. The cylinder decreased to 3.33 D with MyoRing alone and to 3.31 D with MyoRing + CXL. Corneal thickness remained nearly unchanged (from 433.69 ± 38.76 to 434.21 ± 34.98) in MyoRing group and decreased from baseline (from 426.93 ± 46.58 to 401.24 ± 39.12 µm) in MyoRing + CXL group 36 months postoperatively, which corresponds with pachymetry reduction after conventional CXL. CONCLUSION: Both MyoRing implantation and MyoRing combined with CXL were effective for treating keratoconus. At 36 months, there were slightly better outcomes in MyoRing + CXL group; however, in MyoRing alone group visual and refractive outcomes were stable overtime. Springer Netherlands 2017-06-15 2018 /pmc/articles/PMC5988788/ /pubmed/28620706 http://dx.doi.org/10.1007/s10792-017-0593-4 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Bikbova, Guzel
Kazakbaeva, Gyulli
Bikbov, Mukharram
Usubov, Emin
Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title_full Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title_fullStr Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title_full_unstemmed Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title_short Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
title_sort complete corneal ring (myoring) implantation versus myoring implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988788/
https://www.ncbi.nlm.nih.gov/pubmed/28620706
http://dx.doi.org/10.1007/s10792-017-0593-4
work_keys_str_mv AT bikbovaguzel completecornealringmyoringimplantationversusmyoringimplantationcombinedwithcornealcollagencrosslinkingforkeratoconus3yearfollowup
AT kazakbaevagyulli completecornealringmyoringimplantationversusmyoringimplantationcombinedwithcornealcollagencrosslinkingforkeratoconus3yearfollowup
AT bikbovmukharram completecornealringmyoringimplantationversusmyoringimplantationcombinedwithcornealcollagencrosslinkingforkeratoconus3yearfollowup
AT usubovemin completecornealringmyoringimplantationversusmyoringimplantationcombinedwithcornealcollagencrosslinkingforkeratoconus3yearfollowup